Real-World Experience of the One-Year Efficacy of Rifaximin Add-On to Lactulose Is Superior to Lactulose Alone in Patients with Cirrhosis Complicated with Recurrent Hepatic Encephalopathy in Taiwan

Background: Hepatic encephalopathy (HE), a neuropsychiatric complication of decompensated cirrhosis, is associated with high mortality and high risk of recurrence. Rifaximin add-on to lactulose for 3 to 6 months is recommended for the prevention of recurrent episodes of HE after the second episode....

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Ching, Huang, Chien-Hao, Tseng, Hsiao-Jung, Yang, Fang-Chen, Chien, Rong-Nan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226737/
https://www.ncbi.nlm.nih.gov/pubmed/34071787
http://dx.doi.org/10.3390/jpm11060478

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226737/
https://www.ncbi.nlm.nih.gov/pubmed/34071787
http://dx.doi.org/10.3390/jpm11060478

Ejemplares similares